Laboratory Corporation of America has launched ColoSure, a stool-based testing service for colorectal cancer screening. The test, which uses OncoMethylome’s reagents, is included in the American Cancer Society’s colorectal cancer screening guidelines.
ColoSure is a PCR test that detects methylation of the vimentin DNA marker and determines the presence of colorectal cancer in patients who are traditionally non-compliant to colorectal screening.